Linscomb Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $534K | Sell |
1,065
-1,208
| -53% | -$580K | 0.02% | 222 |
|
|
2026
Q1 | $1.12M | Buy |
2,273
+940
| +71% | +$510K | 0.05% | 189 |
|
|
2025
Q4 | $772K | Sell |
1,333
-6
| -0.4% | -$3.39K | 0.03% | 195 |
|
|
2025
Q3 | $649K | Sell |
1,339
-12
| -0.9% | -$5.59K | 0.03% | 212 |
|
|
2025
Q2 | $548K | Hold |
1,351
| – | – | 0.03% | 223 |
|
|
2025
Q1 | $672K | Sell |
1,351
-21
| -2% | -$11.4K | 0.03% | 202 |
|
|
2024
Q4 | $714K | Hold |
1,372
| – | – | 0.04% | 196 |
|
|
2024
Q3 | $849K | Sell |
1,372
-113
| -8% | -$66.9K | 0.04% | 176 |
|
|
2024
Q2 | $821K | Sell |
1,485
-27
| -2% | -$15.5K | 0.04% | 173 |
|
|
2024
Q1 | $879K | Sell |
1,512
-1,613
| -52% | -$905K | 0.05% | 170 |
|
|
2023
Q4 | $1.66M | Buy |
3,125
+28
| +0.9% | +$13.6K | 0.09% | 136 |
|
|
2023
Q3 | $1.57M | Sell |
3,097
-149
| -5% | -$79.4K | 0.09% | 135 |
|
|
2023
Q2 | $1.69M | Sell |
3,246
-44
| -1% | -$23.7K | 0.09% | 138 |
|
|
2023
Q1 | $1.9M | Sell |
3,290
-1,119
| -25% | -$631K | 0.1% | 133 |
|
|
2022
Q4 | $2.43M | Buy |
4,409
+1,089
| +33% | +$577K | 0.12% | 129 |
|
|
2022
Q3 | $1.68M | Buy |
3,320
+1
| +0% | +$560 | 0.1% | 129 |
|
|
2022
Q2 | $1.8M | Sell |
3,319
-1,028
| -24% | -$566K | 0.1% | 130 |
|
|
2022
Q1 | $2.57M | Buy |
4,347
+2
| +0% | +$1.15K | 0.12% | 119 |
|
|
2021
Q4 | $2.9M | Sell |
4,345
-10
| -0.2% | -$6.24K | 0.14% | 116 |
|
|
2021
Q3 | $2.49M | Buy |
4,355
+1
| +0% | +$549 | 0.13% | 120 |
|
|
2021
Q2 | $2.2M | Sell |
4,354
-303
| -7% | -$143K | 0.11% | 121 |
|
|
2021
Q1 | $2.13M | Buy |
4,657
+88
| +2% | +$42K | 0.12% | 120 |
|
|
2020
Q4 | $2.13M | Buy |
4,569
+19
| +0.4% | +$8.91K | 0.13% | 113 |
|
|
2020
Q3 | $2.01M | Buy |
4,550
+31
| +0.7% | +$12.8K | 0.14% | 106 |
|
|
2020
Q2 | $1.64M | Buy |
4,519
+300
| +7% | +$101K | 0.12% | 110 |
|
|
2020
Q1 | $1.2M | Sell |
4,219
-250
| -6% | -$78.8K | 0.11% | 119 |
|
|
2019
Q4 | $1.45M | Sell |
4,469
-4
| -0.1% | -$1.21K | 0.09% | 150 |
|
|
2019
Q3 | $1.3M | Buy |
4,473
+4
| +0.1% | +$1.15K | 0.1% | 108 |
|
|
2019
Q2 | $1.31M | Sell |
4,469
-35
| -0.8% | -$9.64K | 0.11% | 106 |
|
|
2019
Q1 | $1.23M | Buy |
4,504
+22
| +0.5% | +$5.47K | 0.1% | 106 |
|
|
2018
Q4 | $1M | Buy |
4,482
+87
| +2% | +$20.4K | 0.09% | 107 |
|
|
2018
Q3 | $1.07M | Buy |
4,395
+3
| +0.1% | +$690 | 0.09% | 110 |
|
|
2018
Q2 | $910K | Buy |
4,392
+2
| +0% | +$425 | 0.08% | 120 |
|
|
2018
Q1 | $906K | Sell |
4,390
-44
| -1% | -$9.23K | 0.08% | 117 |
|
|
2017
Q4 | $842K | Buy |
4,434
+2
| +0% | +$383 | 0.07% | 128 |
|
|
2017
Q3 | $838K | Buy |
4,432
+3
| +0.1% | +$543 | 0.07% | 123 |
|
|
2017
Q2 | $773K | Sell |
4,429
-85
| -2% | -$14.3K | 0.07% | 126 |
|
|
2017
Q1 | $693K | Sell |
4,514
-290
| -6% | -$44.3K | 0.06% | 136 |
|
|
2016
Q4 | $678K | Sell |
4,804
-94
| -2% | -$13.9K | 0.06% | 142 |
|
|
2016
Q3 | $779K | Sell |
4,898
-27
| -0.5% | -$4.16K | 0.08% | 123 |
|
|
2016
Q2 | $728K | Sell |
4,925
-193
| -4% | -$28.5K | 0.07% | 126 |
|
|
2016
Q1 | $725K | Buy |
5,118
+267
| +6% | +$35.8K | 0.08% | 125 |
|
|
2015
Q4 | $688K | Buy |
4,851
+3
| +0.1% | +$400 | 0.08% | 124 |
|
|
2015
Q3 | $593K | Sell |
4,848
-69
| -1% | -$8.99K | 0.07% | 137 |
|
|
2015
Q2 | $638K | Buy |
4,917
+34
| +0.7% | +$4.43K | 0.07% | 141 |
|
|
2015
Q1 | $656K | Buy |
4,883
+30
| +0.6% | +$3.87K | 0.07% | 144 |
|
|
2014
Q4 | $608K | Sell |
4,853
-23
| -0.5% | -$2.8K | 0.07% | 147 |
|
|
2014
Q3 | $593K | Buy |
4,876
+41
| +0.8% | +$4.99K | 0.07% | 153 |
|
|
2014
Q2 | $571K | Sell |
4,835
-17
| -0.4% | -$2K | 0.06% | 161 |
|
|
2014
Q1 | $583K | Buy |
4,852
+1,953
| +67% | +$232K | 0.06% | 153 |
|
|
2013
Q4 | $323K | Buy |
2,899
+4
| +0.1% | +$398 | 0.04% | 180 |
|
|
2013
Q3 | $267K | Buy |
2,895
+3
| +0.1% | +$271 | 0.04% | 195 |
|
|
2013
Q2 | $245K | Buy |
+2,892
| New | +$241K | 0.03% | 204 |
|
Other funds holding TMO
Linscomb Wealth's TMO Position: Q2 2026 in Review
Linscomb Wealth reduced its Thermo Fisher Scientific (TMO) stake by 53% in Q2 2026, selling an estimated $580K and leaving 1,065 shares worth $534K. The position accounts for 0.02% of the portfolio, ranked #222.
Linscomb Wealth first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.9M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Linscomb Wealth held 1,065 shares of Thermo Fisher Scientific worth $534K as of Q2 2026.
- Linscomb Wealth sold 1,208 Thermo Fisher Scientific shares in Q2 2026, an estimated $580K.
- Thermo Fisher Scientific made up 0.02% of Linscomb Wealth's portfolio in Q2 2026, its #222 holding.
- Linscomb Wealth first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Linscomb Wealth's Thermo Fisher Scientific position peaked at $2.9M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Linscomb Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.